Mohamed Atta, PhD

1994- Life Science Division CEA-Grenoble 
"Mohamed Atta"
Mean distance: 10.05
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Thielmann M, Corteville D, Szabo G, et al. (2021) Teprasiran, A Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study. Circulation
Deonaraine KK, Carlucci PM, Fava A, et al. (2021) Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network. Lupus Science & Medicine. 8
Cervantes CE, Kant S, Atta M. (2021) The Link between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy. Drug Metabolism Letters
Abdelsalam H, Atta MM, Osman W, et al. (2021) Two-dimensional quantum dots for highly efficient heterojunction solar cells. Journal of Colloid and Interface Science. 603: 48-57
Atta M, Zook K, Brown T, et al. (2021) Racial Adjustment Adversely Affects Glomerular Filtration Estimates in African Americans Living with HIV. Journal of the American Society of Nephrology : Jasn
Al Ammary F, Yu S, Muzaale AD, et al. (2021) Long-term Kidney Function and Survival in Recipients of Allografts from Living Kidney Donors with Hypertension: A National Cohort Study. Transplant International : Official Journal of the European Society For Organ Transplantation
Roblin C, Chiumento S, Jacqueline C, et al. (2021) The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health. International Journal of Molecular Sciences. 22
Alkhatib MH, Kant S, Menez S, et al. (2021) Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus. Journal of Nephrology
Chedid A, Rossi GM, Peyronel F, et al. (2020) Low-Level Proteinuria in Systemic Lupus Erythematosus. Kidney International Reports. 5: 2333-2340
Kant S, Atta MG. (2020) Therapeutic advances in Fabry disease: The future awaits. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 131: 110779
See more...